Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients

Transplantation

Volumn 67, Issue 3, 1999, Pages 399-403

  Dockrell, David H ^a   Mendez, Julio C ^a   Jones, Mary ^a   Harmsen, William S ^a   Ilstrup, Duane M ^a   Smith, Thomas F ^a   Wiesner, Russell H ^b   Krom, Ruud A F ^b   Paya, Carlos V ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic ^*

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANTIFUNGAL ACTIVITY; ARTICLE; CRYOPRECIPITATE; DATA ANALYSIS; DISEASE ASSOCIATION; GASTROINTESTINAL BIOPSY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; LIVER DISEASE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MYCOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0033557299     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199902150-00010     Document Type: Article

References (39)

1. Wajszczuk CP, Dummer JS, Ho M, Van Thiel DH, Starzl TE, Iwatsuki S, et al. Fungal infections in liver transplant recipients. Transplantation 1985; 40: 347.
2. Paya CV, Hermans PE, Washington JA II, et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989; 64: 555.
3. Fulginiti VA, Scribner R, Groth CG, et al. Infection in recipients of liver homografts. N Engl J Med 1968; 279: 619.
4. Castaldo P, Stratta RJ, Wood RP, et al. Clinical spectrum of fungal infections after orthotopic liver transplantation. Arch Surg 1991; 126: 149.
5. Colonna JO II, Winston DJ, Brill JE, et al. Infectious complications in liver transplantation. Arch Surg 1988; 123: 360.
6. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16: 655.
7. Rubin RH. Fungal and bacterial infections in the immunocompromised host. Eur J Clin Microbiol Infect Dis 1993; 12: S42.
8. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596.
9. Yamanishi K, Shiraki K, Kondo T, et al. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet 1988; 1: 1065.
10. Oren H, Sobel JD. Human herpesvirus type 6: review. Clin Infect Dis 1992; 14: 41.
11. Robinson WS. Human herpesvirus 6. Curr Clin Top Infect Dis 1994; 14: 159.
12. Breese Hall C. Human herpesviruses at sixes, sevens, and more. Ann Intern Med 1997; 127: 481.
13. Dewhurst S. Newly discovered human herpesviruses (HHV-6 and HHV-7). Curr Opin Infect Dis 1994; 7: 238.
14. Flamand L, Gosseline J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995; 85: 1263.
15. Morris DJ, Littler E, Arrand JR, et al. Human herpesvirus 6 infection in renal-transplant recipients. N Engl J Med 1989; 320: 1560.
16. Robert C, Agut H, Lunel-Fabiani F, Leger PH. Infection a herpesvirus human-6 et hepatite chez les transplantes cardiaques. La Press Médicale 1994; 23: 1209.
17. Dockrell DH, Prada J, Jones MF, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis 1997; 176: 1135.
18. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle M-L, Wolfe P, Obert G. Longitudinal study of human herpesvirus 6 infection in organ transplant recipients. Clin Infect Dis 1996; 22: 171.
19. Paulin T, Ringdén O, Nilsson B, Lönnqvist B, Gahrton G. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment. Transplantation 1987; 43: 393.
20. Patel R, Portela D, Badley AD, et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation 1996; 62: 926.
21. Ward KN, Sheldon MJ, Gray JJ. Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus-6 antibodies in immunosuppressed organ graft recipients: absence of virus cross-reactivity and evidence for virus interaction. J Med Virol 1991; 34: 258.
22. Hadley S, Karchmer AW. Fungal infections in solid organ transplant recipients. In: Rubin R, ed. Infectious Diseases Clinics of North America. Philadelphia: WB Saunders Co., 1995; 9: 1045.
23. Hamilton JR, Overall JC, Glasgow LA. Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun 1976; 14: 982.
24. Hamilton JR, Overall JC, Glasgow LA. Synergistic infection with murine cytomegalovirus and Candida albicans in mice. J Infect Dis 1977; 135: 918.
25. Osman HK, Peiris JS, Taylor CD, Warwicker P, Jarrett RF, Madeley CR. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression? J Med Virol 1996; 48: 295.
26. Anderson RA, Liu DX, Gompels UA. Definition of a human herpesvirus-6 Betaherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology 1996; 217: 517.
27. Wagner JA, Ross H, Hunt S, et al. Prophylactic ganciclovir treatment reduces fungal as well as cytomegalovirus infections after heart transplantation. Transplantation 1995; 60: 1473.
28. Badley AD, Seaberg EC, et al. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK liver transplantation database. Transplantation 1997; 64: 66.
29. Reymen D, Naesens L, Balzarini J, Holy A, Dvorakova H, De Clercq E. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral Res 1995; 28: 343.
30. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124: 1065.
31. Ablashi DV, Lusso P, Hung C-L, et al. Utilization of human hematopoietic cell lines for the propagation and characteriza-tion of HBLV (human herpesvirus 6). Int J Cancer 1988; 42: 787.
32. Lusso P, Gallo RC, DeRocco SE, Markham PD. CD4 is not the membrane receptor for HHV-6. Lancet 1989; 2: 730.
33. Flamand L, Gosselin J, D'Addario M, et al. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 1991; 65: 5105.
34. Dood CL, Greenspan D, Katz MH, Westenhouse JL, Feigal DW, Greenspan JS. Oral candidiasis in HIV infection: pseudomembranous and erythematous candidiasis show similar rates of progression of AIDS. AIDS 1991; 5: 1339.
35. Klapholz A, Salomon N, Perman DC, Talavera W. Aspergillosis in the acquired immunodeficiency syndrome. Chest 1991; 100: 1614.
36. Rubin RH. Cytomegalovirus disease and allograft loss after organ transplantation. Clin Infect Dis 1998; 26: 871.
37. de Otero J, Gavalda J, Murio E, Calico I, Llopart L, Rosello J, et al. Cytomegalovirus disease as a risk factor for graft loss and death after orthotopic liver transplantation. Clin Infect Dis 1998; 26: 865.
38. Okuno T, Higashi K, Shiraki K, et al. Human herpesvirus 6 in renal transplantation. Transplantation 1990; 49: 519.
39. Merlino C, Giacchino F, Segoloni GP, Ponzi AN. Human herpes-virus 6 and renal transplantation. Transplantation 1992; 53: 1382.